Theodore S. Nowicki, Ph.D.
Affiliations: | 2013 | Microbiology and Immunology | New York Medical College, New York, NY, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Theodore Nowicki"Parents
Sign in to add mentorJan Geliebter | grad student | 2013 | New York Medical College | |
(The urokinase plasminogen activator system in papillary thyroid carcinoma: A metastatic biomarker and potential therapeutic target.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kummer NT, Nowicki TS, Azzi JP, et al. (2012) Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. Journal of Cellular Biochemistry. 113: 1998-2008 |
Nowicki TS, Moscatello AL, Shin E, et al. (2011) The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target. The Journal of Clinical Endocrinology and Metabolism. 96: 3062-4 |
Nowicki TS, Zhao H, Darzynkiewicz Z, et al. (2011) Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle (Georgetown, Tex.). 10: 100-7 |
MacEwan M, Mehta V, Darr EA, et al. (2011) Abstract 1502: Increased expression of KLK7 and KLK10 in papillary thyroid cancer Cancer Research. 71: 1502-1502 |
Nowicki TS, Zhao H, Darzynkiewicz Z, et al. (2011) Abstract 1406: Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling, and induces senescence in papillary thyroid carcinoma cells Cancer Research. 71: 1406-1406 |
Darr EA, Nowicki TS, Kummer N, et al. (2011) Abstract 1063: BRAFV600Estatus predicts higher uPA levels in papillary thyroid cancer Cancer Research. 71: 1063-1063 |
Ashlie Darr E, Nowicki TS, MacEwan ME, et al. (2011) BRAFV600E is associated with increased uPA levels in papillary thyroid cancer Laryngoscope. 121 |
Nowicki TS, Kummer NT, Iacob C, et al. (2010) Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. The Laryngoscope. 120: 1383-90 |
Nowicki TS, Kummer NT, Iacob C, et al. (2010) Abstract 520: Inhibition of uPAR and uPA reduces invasion and degradative potential in papillary thyroid carcinoma cells Cancer Research. 70: 520-520 |
Mehta V, Cooke SL, Yu G, et al. (2010) Increased estrogen and the risk of papillary thyroid cancer Laryngoscope. 120: S16 |